Pictet Asset Management’s Air Products & Chemicals APD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.2M Sell
75,701
-11,224
-13% -$3.26M 0.02% 512
2026
Q1
$25.3M Sell
86,925
-24,594
-22% -$6.78M 0.03% 447
2025
Q4
$27.5M Buy
111,519
+22,781
+26% +$5.77M 0.03% 449
2025
Q3
$24.2M Sell
88,738
-1,429
-2% -$414K 0.02% 477
2025
Q2
$25.4M Sell
90,167
-32,757
-27% -$8.96M 0.03% 446
2025
Q1
$36.3M Sell
122,924
-10,010
-8% -$3.09M 0.04% 368
2024
Q4
$38.6M Buy
132,934
+16,387
+14% +$5.15M 0.04% 350
2024
Q3
$34.7M Buy
116,547
+4,351
+4% +$1.19M 0.04% 364
2024
Q2
$29M Buy
112,196
+22,264
+25% +$5.65M 0.03% 381
2024
Q1
$21.8M Sell
89,932
-2,438
-3% -$597K 0.02% 478
2023
Q4
$25.3M Buy
92,370
+8
+0% +$2.2K 0.03% 421
2023
Q3
$26.2M Buy
+92,362
New +$27.1M 0.03% 398

Other funds holding APD

Pictet Asset Management's APD Position: Q2 2026 in Review

Pictet Asset Management reduced its Air Products & Chemicals (APD) stake by 13% in Q2 2026, selling an estimated $3.26M and leaving 75,701 shares worth $22.2M. The position accounts for 0.02% of the portfolio, ranked #512.

Pictet Asset Management first reported a position in APD in Q3 2023 and has held it in 12 quarters since. The position peaked at $38.6M in Q4 2024. 1,765 funds tracked by Wall St. Rank hold APD as of Q2 2026.

  • Pictet Asset Management held 75,701 shares of Air Products & Chemicals worth $22.2M as of Q2 2026.
  • Pictet Asset Management sold 11,224 Air Products & Chemicals shares in Q2 2026, an estimated $3.26M.
  • Air Products & Chemicals made up 0.02% of Pictet Asset Management's portfolio in Q2 2026, its #512 holding.
  • Pictet Asset Management first reported a position in Air Products & Chemicals in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Air Products & Chemicals position peaked at $38.6M in Q4 2024.
  • 1,765 funds tracked by Wall St. Rank held Air Products & Chemicals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.